Publications

PUBLICATIONS

Li Z, Li T, Liu M, Ivanovic T. Hemagglutinin stability determines influenza A virus susceptibility to a broad-spectrum fusion inhibitor Arbidol. ACS Infect. Dis. https://doi.org/10.1021/acsinfecdis.2c00178 [Editor’s Choice]

Li Z, Li T, Liu M, Ivanovic T. Hemagglutinin stability determines influenza A virus susceptibility to a broad-spectrum fusion inhibitor Arbidol. BioRxiv. https://doi.org/10.1101/2022.01.11.475941 [PDF]

Li T, Li Z, Deans EE, Mittler E, Liu M, Chandran K, Ivanovic T. The shape of pleomorphic virions determines resistance to cell-entry pressure. Nat. Microbiol. 6(5):617-629. Epub 2021 [PDF] [Media coverage: Nature Microbiology, BrandeisNOW]

Li T, Li Z, Deans EE, Mittler E, Liu M, Chandran K, Ivanovic T. Phenotypic heterogeneity in particle size is a viral mechanism of persistence. BioRxiv. https://doi.org/10.1101/843177 [PDF] [Media coverage: Photonics Online]

Ivanovic T*, Harrison SC. Distinct functional determinants of influenza hemagglutinin-mediated membrane fusion. eLife 2015;10.7554/eLife.11009. 2015 *Corresponding author [PDF]

Blaising J, Levy PL, Gondeau C, Phelip C, Varbanov M, Teissier E, Ruggiero F, Polyak SJ, Oberlies NH, Ivanovic T, Boulant S, Pecheur E-I. Silibinin inhibits hepatitis C virus entry into hepatocytes by hindering clathrin-dependent trafficking. Cell. Microbiol. 15(11):1866-1882. 2013 [PDF]

Ivanovic T*, Choi JL, Whelan SP, van Oijen AM, Harrison SC*. Influenza-virus membrane fusion: cooperative fold-back of stochastically induced hemagglutinin intermediates. eLife 2013;2:e00333. *Co-corresponding authors [PDF] [Media coverage: Harvard Medical School]

Ivanovic T, Rozendaal R, Floyd DL, Popovic M, van Oijen AM, Harrison SC. Kinetics of proton transport into influenza virions by the viral M2 channel. PLoS One 7(3):e31566. Epub 2012 [PDF]

Ivanovic T*, Boulant S*, Ehrlich M, Demidenko AA, Arnold MM, Kirchhausen T, Nibert ML. Recruitment of cellular clathrin to viral factories and disruption of clathrin-dependent trafficking. Traffic 12(9):1179-95. 2011 *Equal contribution [PDF]

Zhang L, Agosto MA, Ivanovic T, King DS, Nibert ML, Harrison SC. Requirements for the formation of membrane pores by the reovirus myristoylated µ1N peptide. J. Virology 83(14): 7004-14. 2009 [PDF]

Agosto MA, Myers KS, Ivanovic T, Nibert ML. A positive-feedback mechanism promotes reovirus particle conversion to the intermediate associated with membrane penetration. PNAS 105(30):10571-6. 2008 [PDF]

Ivanovic T, Agosto MA, Zhang L, Chandran K, Harrison SC, Nibert ML. Peptides released from reovirus outer capsid form membrane pores that recruit virus particles. EMBO J. 27(8):1289-98. 2008 [PDF]

Ivanovic T, Agosto MA, Chandran K, Nibert ML. A role for molecular chaperone Hsc70 in reovirus outer-capsid disassembly. J. Biol. Chem. 282(16):12210-12219. 2007 [PDF]

Agosto MA, Ivanovic T, Nibert ML. Mammalian reovirus, a nonfusogenic nonenveloped virus, forms size-selective pores in a model membrane. PNAS 103(44):16496-501. 2006 [PDF]

Biorn AC, Cocklin S, Madani N, Si Z, Ivanovic T, Samanen J, Van Ryk DI, Pantophlet R, Burton DR, Freire E, Sodroski J, Chaiken IM. Mode of action for linear peptide inhibitors of HIV-1 gp120 interactions. Biochemistry 43(7):1928-38. 2004 [PDF]

Chakrabarti LA, Metzner KJ, Ivanovic T, Cheng H, Louis-Virelizier J, Connor RI, Cheng-Mayer C. A truncated form of Nef selected during pathogenic reversion of simian immunodeficiency virus SIVmac239Deltanef increases viral replication. J. Virology 77(2):1245-56. 2003 [PDF]

Chakrabarti LA, Ivanovic T, Cheng-Mayer C. Properties of the surface envelope glycoprotein associated with virulence of simian-human immunodeficiency virus SHIVSF33A molecular clones. J. Virology 76(4): 1588-99. 2002 [PDF]

FUNDING